Funding options, page-13

First 13 Last

Share
Profile

Follow
oxxa23

6,019 Posts.

1160

27/04/23

17:44

Post #: 67486780
Share

Originally posted by ceviche ↑

@oxxa23

Two somewhat different options,

1. a deal on the product MPS or distribution rights with equity or royalties on iPPS,

OR

2. CR across the board.

BRN went down the LDA route. A CR deal in which the company, say PAR, get the right to PUT shares to LDA at a discount to the Volume Weighted share price at the time. One advantage is smaller amounts can be obtained as needed. Another is LDA don't know when the put options will be exercised.

WBT have tried two methods, Firstly they offered deep-in-the-money options to be exercised a fair way out i think over six months So holders had plenty of time to look for progress. That worked well because the share price went up and it was profitable to sell shares and exercise. The reason the share price went up was that WBT were beating their milestones.

The second more typical approach was, after reaching some milestones, they did a standard CR. The share price had risen sharply. Then it fell sharply to the CR price. How come, you might ask --. (i wrote to ASIC - not about WBT they had nothing to gain.).

My preference is a deal on MPS, but i don't think it will get as much as needed to go all the way to Registration, but it might delay a CR until the price of PAR has risen.

Who else, BigPharma?. My erstwhile hope is CSL.

IMO. DYOR.

Expand

Yeah, of course mps deal or oa deal is preference... I just meant interim funding if needed until a great mps or oa deal eventuated....

PAR Price at posting: $1.01 Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

ARB

Court process clears way for ARB to buy up 4 Wheel Parts business in the US

OCT

Octava Minerals joins the antimony train with high-grades on the radar at Yallagong, WA

Tonight's US CPI data could set the tone for November. What are markets expecting?

ARV

Smallcap Artemis Res' jumps 23% on six digit gold grade rockchip find at Titan

IMA

Issues emerging as Australian companies tackle critical minerals challenge

There are more pages in this discussion • 8 more messages in this thread...

First 13 Last

Add PAR (ASX) to my watchlist

(20min delay)
Last 21.0¢		Change 0.015(7.69%)		Mkt cap ! $73.55M

Open	High	Low	Value	Volume
20.5¢	21.0¢	20.0¢	$216.0K	1.057M

Buyers (Bids)

No.	Vol.	Price($)
8	143324	20.0¢

Sellers (Offers)

Price($)	Vol.	No.
21.0¢	44935	3

View Market Depth

No.	Vol.	Price($)
7	138349	0.200
9	191984	0.195
15	199884	0.190
6	161140	0.185
16	784128	0.180

Price($)	Vol.	No.
0.210	44935	3
0.215	132157	4
0.220	82155	7
0.225	31604	3
0.230	33834	4

Last trade - 16.10pm 10/10/2024 (20 minute delay)

PAR (ASX) Chart

Funding options, page-13

Court process clears way for ARB to buy up 4 Wheel Parts business in the US

Octava Minerals joins the antimony train with high-grades on the radar at Yallagong, WA

Tonight's US CPI data could set the tone for November. What are markets expecting?

Smallcap Artemis Res' jumps 23% on six digit gold grade rockchip find at Titan

Issues emerging as Australian companies tackle critical minerals challenge

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Funding options, page-13

Top Stories

Court process clears way for ARB to buy up 4 Wheel Parts business in the US

Octava Minerals joins the antimony train with high-grades on the radar at Yallagong, WA

Tonight's US CPI data could set the tone for November. What are markets expecting?

Smallcap Artemis Res' jumps 23% on six digit gold grade rockchip find at Titan

Issues emerging as Australian companies tackle critical minerals challenge

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News